Vir Bio 8-K Filing
Vir Biotechnology files 8-K with SEC, disclosing executive changes and shareholder vote results. The filing includes updates on compensatory arrangements for certain officers.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.